As of Apr 28
| +0.0021 / +0.55%|
The 1 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 0.90, with a high estimate of 0.90 and a low estimate of 0.90. The median estimate represents a +135.54% increase from the last price of 0.38.
The current consensus among 1 polled investment analysts is to Hold stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.